Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

PHASE3CompletedINTERVENTIONAL
Enrollment

1,034

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

November 30, 2005

Conditions
Hepatitis A
Interventions
BIOLOGICAL

Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY